Rapid Recap: Optimizing Care for HER2 (ERBB2) Mutations
This educational series is designed to strengthen clinicians’ knowledge, skills, and confidence in the identification, diagnosis, and management of HER2 (ERBB2)–mutated metastatic non–small cell lung cancer (mNSCLC).
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.